Endothelial dysfunction in psoriasis and type 2 diabetes in terms of comorbidity

Bibliography:
1. Dovzhanskij S. I., Utc S. R. Psoriaz i psoriaticheskaja bolezn». Saratov: SGU. 1992; 2. Kubanova A.A., Tihonova L.N. Dermatovenerologija v Rossii. real»nost» i perspektivy // Vestnik dermatologii i ven-erologii. 2004. №2. S. 4-11; 3. Immunnye mehanizmy psoriaza: novye strategii biolog-icheskoj terapii /A.A. Kubanova, A.A. Kubanov, Dzh. F. [i dr.] // Vestnik dermatologii i venerologii. 2010. № 1. S. 35-47; 4. The risk of mortality in patients with psoriasis / J. M. Gel-fand, A. B. Troxel, J.D. Lewis [et al.] //Arch Dermatol. 2007. № 143. P. 1493-1499; 5. Griffiths СЕМ, Barker JNWN. Pathogenesis and clinical features of psoriasis // Lancet. 2007. № 370. P. 263-271; 6. Risk of myocardial infarction in patients with psoriasis / Gelfand J.M., Neimann A.L., Shin D.B. [et al.]//JAMA. 2006. № 29. P. 1735-1741; 7. FeinsteinA.R. Pre-therapeutic classification of co-morbidity in chronic disease //Journal Chronic Disease. 1970. № 23 (7). P. 455-468; 8. Kochergin N., Smirnova L., Potekaev N., Bilalova U. Psoriaz: komorbidnosti i komedikacii // Vrach. 2009. № 5. S. 15-20; 9. Vertkin A.L., Rumjancev M.A., Skotnikov A. S. Komorbid-nost» v klinicheskoj praktike. Ch. 1 //Arhiv vnutrennej mediciny 2011. №1.S. 14-19; 10. Aronow W. S. Prevalence of CAD, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function //Am. J. Card. 2000. № 86. S. 1142-1143; 11. Wolff J.L., Starfield В., Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in elderly //Arch. Inter. Med. 2002. № 162. P. 2269-2276; 12. Performance status of health care facilities changes with risk adjustment of HbA1c / Q. Zhang, M. Safford, J. Otten-weller [et al.] // Diabetes Care. 2000. № 23. S. 919-927; 13. Bochkov N.P Klinicheskaja genetika. M.: Medicina, 1997; 14. Tkachenko S. G., Kondrashova V. B. Kardiometaboli-cheskij risk u bol»nyh psoriazom // Dermatologija i venerologija. 2010. №48(2). S. 11-16; 15. Mamedov M. N. Rukovodstvo po diagnostike i lecheni-ju metabolicheskogo sindroma. M.: Mul»tiprint, 2005; 16. Lakka H.M., Laaksonen D.E., Lakka ТА. The metabolic syndrome and total cardiovascular disease mortality in mid-dleaged men // JAMA. 2002. № 288 (12). S. 2709-2716; 17. Belovol A. N. Disfunkcija sosudistogo jendotelija u bol»nyh psoriazom // Ukrainskij zhurnal dermatol., venerol., kos-metol. 2010. №36(1). S. 17-21; 18. Shkol»nik M. N., Vasjuk Ju.A., Perlamutrov Ju.N., Shkol»nik E. L. Sovremennye predstavlenija ob immunopato-geneze psoriaza: perspektivy primenenija statinov// Klinicheskaja dermatol. i venerol. 2008. № 4. S. 10-17; 19. Hlebnikova A. N., Marycheva N.V.. Osobennosti naru-zhnoj terapii patologii kozhi u bol»nyh saharnym diabetom // Klinicheskaja dermatol. i venerol. 2011. № 6. S. 52-58; 20. Dreval» A. V. Lechenie saharnogo diabeta i soputstvu-jushhih zabolevanij. M.: Jeksmo, 2010; 21. Dermatozy v jendokrinologicheskoj praktike / T. B. Morgunova, L. Ja. Rozhinskaja, A. N. L»vov [i dr.] // Rossijskij zhurnal kozh. i ven. boleznej. 2010. № 4. S. 20-27; 22. Ferringer T, Miller O.F. Cutaneous manifestations of diabetes mellitus // Dermatol. Clin. 2002. № 20 (3). P. 483-492; 23. Cox N. H. Diabetes and the skin: an update for dermatologists// Expert Rev. Dermatol. 2007. № 2. P. 305-316; 24. QureA.A., Choi H.K Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses // Arch. Dermatol. 2009. № 145 (4). P. 379-382; 25. Kalus Andrea A., Chien Andy J., Olerud John E. Sa-harnyj diabet i drugie jendokrinnye zabolevanija // Dermatologija Ficpatrika v klinicheskoj praktike: v 3 t. / pod red. A.A. Kubanovoj [i dr.]. M.: Binom, 2012; 26. Wojas-Pelc A., Rajzer L., Rajzer M. Psoriasis and cardiovascular disorders // Przegl. Lek. 2002. № 59 (10). P. 844-847; 27. Petzelbauer Peter, Peng Lisan S., Pober Jordan S. Jendotelij pri vospalenii i angiogeneze // Dermatologija Ficpatrika v klinicheskoj praktike: v 3 t. / pod red. A.A. Kubanovoj [i dr.]. M.: Binom, 2012; 28. Metel»skaja V. A., Gumanova N.G. Skrining-metod opredelenija urovnja metabolitov azota v syvorotke krovi // Klin, lab. diagnostika. 2005. № 6. S. 15-18; 29. Michet С. J. Hip involvement in psoriatic arthritis //Ann. Rheum. Dis. 2009. № 60 (1). P. 220-221; 30. Kolls J.K., Linden A. lnterleukin-17 family members and inflammation // Immunity. 2004. № 21. P. 467; 31. Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human melanoma / D.A. Oble [et al.] // Cancer Immun. 2009. № 9. P. 3; 32. Corthay A. How do regulatory T cells work? // Scand. J. Immunol. 2009. № 70. P. 326; 33. Integrins alpha4beta7 and alphaEbeta7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis / J. S. Schechner [et al.] // Lab Invest. 1999. №79. P. 601-607; 34. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1 / E.L. Berg [et al.] // J.Exp. Med. 1991. №174. P. 1461-1466; 35. A unique phenotype of skinassociated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites / L. J. Picker [et al.] //Am.J. Pathol. 1990. № 136. P. 1053-1068; 36. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells / R.C. Fuhlbrigge [et al.] // Nature. 1997. № 389. P. 978-981; 37. Interactions of the skin and nervoussystem / J. С Ansel [et al.] // J Investig Dermatol Symp Proc. 1997. № 2. P. 23; 38. Endothelial cells in physiology and in the pathophysiol-ogy of vascular disorders / D. B. Cines, E. S. Pollak, С A. Buck [et al.] // Blood. 1998. № 91 (10). P. 3527-3561; 39. Kirichuk V.F., Glybochko P. V., Ponomareva A.I. Dis-funkcija jendotelija. Saratov: SGMU, 2008; 40. Qoyyumi A.A. Endothelial function in health and disease; new insights into the genesis of cardiovascular disease // Am. J. Med. 1998. № 105. P. 32-39; 41. Nitric oxide synthase in human and rat lung: immunocy-tochemical and histochemical localization / L. Kobzik, D.S. Bredt, C.J. Lowenstein [et al.] //Am. J. Respir. Cell Mol. Biol. 1993. № 9. P. 371-377; 42. Zatejshhikova A.A., Zatejshhikov D.A. Jendotelial»na-ja reguljacija sosudistogo tonusa: metody issledovanija i klinich-eskoe znachenie // Kardiologija.1998. № 9. S. 68-80; 43. Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits / Qian HuSheng, V. Ne-plioueva, A. Geetha [et al.] // Circulation. 1999. № 99. P. 2979-2982; 44. Insulin suppresses endothelial — secretion of C-type natriuretic peptide, a novel endothelium-derived relaxing peptide / T. Igaki, H. Itoh, S. Suga [et al.] // Diabetes. 1996. № 45 (3). P. 62-64; 45. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats / P. A. Craven, R. K. Studer, F. R. DeRubertis [et al.] // J. Clin. Invest. 1994. №93. P. 311-320; 46. Regulation of expression of the endothelial cell nitric oxide synthase / D.G. Harrison, H. Sayegh, Y. Ohara [et al.] // Clin.Exp. Pharmacol. Physiol. 1996. №23. P. 251-255; 47. Kirichuk V. F., Svistunov A.A., Glybochko P. V. Meh-anizmy sosudisto-trombocitarnogo zvena sistemy gemostaza: kliniko-fiziologicheskie aspekty. Saratov: SGMU, 1998; 48. Gavrilova N.A., Tishhenko O.E. Vlijanie sulodeksida na funkcional»noe sostojanie jendotelija u bol»nyh saharnym di-abetom i diabeticheskoe retinopatiej // Saharnyj diabet. 2011. № 2. S. 66-68; 49. Pokazateli obmena soedinitel»noj tkani pri psoriatich-eskoj bolezni / R.M. Zagrtdinova, P. N. Sharaev, N.A. Koljaseva [i dr.] // Vestnik dermatol. i venerol. 2001. № 5. S. 47-48; 50. Katunina O.R., Rezajkina A.V. Sovremennye pred-stavlenija ob uchastii kozhi v immunnyh processah // Vestnik dermatol. i venerol. 2009. № 2. S. 39-49.